GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: Cardamyst® | MSP-2017 | MSP2017
etripamil is an approved drug
Compound class:
Synthetic organic
|
|
|||||||||||||||||||||||||||||||||||
| References |
|
1. Chu GS, Gupta D. (2021)
Update on Etripamil Nasal Spray for the At-home Treatment of Acute Paroxysmal Supraventricular Tachycardia. Heart Int, 15 (1): 2-6. [PMID:36277324] |
|
2. Ip JE, Wight D, Yue CS, Nguyen D, Plat F, Stambler BS. (2024)
Pharmacokinetics and Pharmacodynamics of Etripamil, an Intranasally Administered, Fast-Acting, Nondihydropyridine Calcium Channel Blocker. Clin Pharmacol Drug Dev, 13 (4): 367-379. [PMID:38315144] |
|
3. Stambler BS, Dorian P, Sager PT, Wight D, Douville P, Potvin D, Shamszad P, Haberman RJ, Kuk RS, Lakkireddy DR et al.. (2018)
Etripamil Nasal Spray for Rapid Conversion of Supraventricular Tachycardia to Sinus Rhythm. J Am Coll Cardiol, 72 (5): 489-497. [PMID:30049309] |